GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » Other Long Term Assets

Blau Farmaceutica (BSP:BLAU3) Other Long Term Assets : R$408 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Blau Farmaceutica Other Long Term Assets?

Blau Farmaceutica's other long-term assets for the quarter that ended in Sep. 2024 was R$408 Mil.

Blau Farmaceutica's quarterly other long-term assets increased from Mar. 2024 (R$401 Mil) to Jun. 2024 (R$406 Mil) and increased from Jun. 2024 (R$406 Mil) to Sep. 2024 (R$408 Mil).

Blau Farmaceutica's annual other long-term assets declined from Dec. 2021 (R$40 Mil) to Dec. 2022 (R$29 Mil) but then increased from Dec. 2022 (R$29 Mil) to Dec. 2023 (R$400 Mil).

Blau Farmaceutica Other Long Term Assets Historical Data

The historical data trend for Blau Farmaceutica's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blau Farmaceutica Other Long Term Assets Chart

Blau Farmaceutica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial 21.86 45.05 40.13 29.45 399.72

Blau Farmaceutica Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 397.85 399.72 401.36 406.07 408.26

Blau Farmaceutica Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Blau Farmaceutica Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » Other Long Term Assets
Comparable Companies
BSP:OFSA3 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NBIX NSE:DIVISLAB BOM:500124 VTRS SZSE:000963 XPAR:IPN SHSE:600085 XTAE:TEVA SHSE:600196
Traded in Other Exchanges
N/A
Address
Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030
Website
https://www.blau.com
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica Headlines

No Headlines